News
Zacks Investment Research on MSN6d
Sanofi & Regeneron's Dupixent Receives FDA Nod for UrticariaSanofi SNY and partner Regeneron REGN announced that the FDA approved Dupixent (dupilumab) for the treatment of chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback